MENU
DVAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Dynavax Technologies (DVAX) Ownership - Who owns Dynavax Technologies?
Dynavax Technologies Corp is a biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2100 Powell Street
Phone
+1 510 848-5100
Employees
408
Web
https://www.dynavax.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.62B
P/E Ratio
31.63
Total Cash
742.3M
Projected Growth
N/A
Total Debt
256.91M
Revenue
232.28M
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash/Share
5.68
Total Debt/Equity
N/A
Revenue/Share
1.80 USD as % of share price
Fundamentals
DVAX
Capitalization
1.62B
P/E Ratio
31.63
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash
742M
Total Cash/Share
5.68
Total Debt
257M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.80%
Revenue
232M
ROE
N/A
Book Value
622M
P/B Ratio
2.64
Cash Flow
N/A
Earnings
-0.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
130K
Current Ratio
13.81
Current Revenue Per Employee
136264.70
Dividends Per Share - Security
N/A
EBITDA
9.67M
Float
N/A
Float - Current
N/A
Gross Income Margin
84.37
Revenue To Assets
-0.64
Shares Held By Institutions
3.06B
Shares Outstanding - Current
131M
Total Liabilities
375M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.662
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel products to prevent and treat infectious diseases
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2100 Powell Street
Phone
+1 510 848-5100
Employees
408
Web
https://www.dynavax.com